Exploring Therapies for Platinum Sensitive & Platinum-Resistant Ovarian Cancer

A medical expert discusses efficacy of approaches such as carboplatin doublets, checkpoint inhibitors, and PARP inhibitors for patients with platinum sensitive and platinum-resistant ovarian cancer.

EP: 1.NCCN Guidelines Update Adds Mirvetuximab Soravtansine Plus Bevacizumab for FRα-Expressing, Platinum-Sensitive Ovarian Cancer

EP: 2.NCCN Guidelines: Implementing New Therapy Options for Ovarian Cancer

Now Viewing

EP: 3.Exploring Therapies for Platinum Sensitive & Platinum-Resistant Ovarian Cancer

EP: 4.MIRASOL trial and DESTINY-PanTumor02 Trial Overview

EP: 5.Tailored Therapy: Decision Making for Ovarian Cancer Treatment

EP: 6.Harnessing Biomarkers & Molecular Profiling in Ovarian Cancer Treatment

EP: 7.Closing Thoughts on the Current Ovarian Cancer Treatment Landscape

Related Videos

Related Content

Advertisement

January 16th 2025

Kent Hospital MPN Initiative Focuses on Supportive Care

Mary Caffrey

Besides Kent Hospital, the Association of Cancer Care Centers worked with Perlmutter Cancer Center at NYU Langone Hospital and Charleston Area Medical Center Vandalia Health in Charleston, West Virginia.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

January 16th 2025

Real-World Evidence Confirms the Benefits of JAK Inhibitors in Patients With Rheumatoid Arthritis

Brooke McCormick

This systematic review of real-world observational studies demonstrated the effectiveness of Janus kinase (JAK) inhibitors in improving treatment adherence, persistence, clinical outcomes, and patient-reported outcomes among US patients with rheumatoid arthritis.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

January 15th 2025

Pain, Fatigue With Bimekizumab for PsA Tied to Swollen Joints

Maggie L. Shaw

Bimekizumab (Bimzelx; UCB Pharma) was approved by the FDA to treat psoriatic arthritis (PsA) on September 23, 2024, based on data from 2 phase 3 trials: BE OPTIMAL and BE COMPLETE.

January 15th 2025

Patients With HIV May Have High Prevalence of Long COVID

Julia Bonavitacola

Although the association between HIV and long COVID was inconclusive, the prevalence of long COVID in patients with HIV was high.

Related Content

Advertisement

January 16th 2025

Kent Hospital MPN Initiative Focuses on Supportive Care

Mary Caffrey

Besides Kent Hospital, the Association of Cancer Care Centers worked with Perlmutter Cancer Center at NYU Langone Hospital and Charleston Area Medical Center Vandalia Health in Charleston, West Virginia.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

January 16th 2025

Real-World Evidence Confirms the Benefits of JAK Inhibitors in Patients With Rheumatoid Arthritis

Brooke McCormick

This systematic review of real-world observational studies demonstrated the effectiveness of Janus kinase (JAK) inhibitors in improving treatment adherence, persistence, clinical outcomes, and patient-reported outcomes among US patients with rheumatoid arthritis.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

January 15th 2025

Pain, Fatigue With Bimekizumab for PsA Tied to Swollen Joints

Maggie L. Shaw

Bimekizumab (Bimzelx; UCB Pharma) was approved by the FDA to treat psoriatic arthritis (PsA) on September 23, 2024, based on data from 2 phase 3 trials: BE OPTIMAL and BE COMPLETE.

January 15th 2025

Patients With HIV May Have High Prevalence of Long COVID

Julia Bonavitacola

Although the association between HIV and long COVID was inconclusive, the prevalence of long COVID in patients with HIV was high.